TrialBreast cancer research : BCR2025

Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone.

James N Ingle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.